Overview

  • Product name
    (-)-Nicotine ditartrate
  • Description
    Potent nAChR agonist
  • Biological description
    Potent nicotinic acetylcholine receptor (nAChR) agonist. Stimulates autonomic ganglia and skeletal muscle neuromuscular junctions. Reduces beta-amyloidosis in a mouse model of Alzheimer's disease. (Ki values are 16.1 (α4β2), 2110 (α7), 520 (α3β4), 270 (α6/α4β4) and 2090 nM (α1β1γδ)).
  • Purity
    > 99%

Properties

References

This product has been referenced in:
  • Rollema H  et al. Pre-clinical properties of the alpha4beta2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence. Br J Pharmacol 160:334-45 (2010). Read more (PubMed: 20331614) »
  • Benowitz NL Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics. Annu Rev Pharmacol Toxicol 49:57-71 (2009). Read more (PubMed: 18834313) »
  • Coolon RA & Cain ME Individual differences in response to novelty and the conditioned locomotor effects of nicotine. Behav Pharmacol 20:322-9 (2009). Read more (PubMed: 19571743) »
  • Nordberg A  et al. Chronic nicotine treatment reduces beta-amyloidosis in the brain of a mouse model of Alzheimer's disease (APPsw). J Neurochem 81:655-8 (2002). Read more (PubMed: 12065674) »

See 0 Publications for this product

Customer reviews and Q&As

There are currently no Customer reviews or Questions for ab120562.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"

Sign up